These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 940540)

  • 41. New approaches to old problems in the clotting of fibrinogen.
    Lorand L
    Ann N Y Acad Sci; 1983 Jun; 408():226-32. PubMed ID: 6575686
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current views on factors of fibrinogen synthesis and catabolism and on their possible role in the etiology of thromboembolic disease and atherosclerosis].
    Lepsanović L
    Med Pregl; 1977; 30(5-6):295-300. PubMed ID: 904588
    [No Abstract]   [Full Text] [Related]  

  • 43. Cross-linked fibrinogen dimers demonstrate a feature of the molecular packing in fibrin fibers.
    Fowler WE; Erickson HP; Hantgan RR; McDonagh J; Hermans J
    Science; 1981 Jan; 211(4479):287-9. PubMed ID: 6108612
    [No Abstract]   [Full Text] [Related]  

  • 44. Controlled defibrination in the treatment of peripheral vascular disease.
    Dormandy JA; Reid HL
    Angiology; 1978 Jan; 29(1):80-8. PubMed ID: 343654
    [No Abstract]   [Full Text] [Related]  

  • 45. Fibrinogen and FDP-models of molecular pathology?
    Gaffney PJ
    Br J Haematol; 1973 Aug; 25(2):271-2. PubMed ID: 4269481
    [No Abstract]   [Full Text] [Related]  

  • 46. Fibrin membrane endowed with biological function. VI. Immobilization of multienzymes of urea cycle.
    Inada Y; Tazawa Y; Attygalle A; Saito Y
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1586-91. PubMed ID: 7447945
    [No Abstract]   [Full Text] [Related]  

  • 47. Human fibrinogen and asialo-fibrinogen: a comparison of coagulation parameters.
    Gentry PA; Alexander B
    Arch Biochem Biophys; 1976 Mar; 173(1):50-7. PubMed ID: 176955
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrin deposits in the Kiil dialyser.
    Björnson J; Kierulf P; Eika C; Godal HC
    Scand J Haematol; 1973; 11(5):379-82. PubMed ID: 4204996
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of factor XIII activity on the rate of lysis of fibrin [proceedings].
    Rampling MW
    Biochem Soc Trans; 1977; 5(5):1438-9. PubMed ID: 923953
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of erythrocyte membrane components on the process of self-conversion of fibrinmonomers].
    Grigor'ev GP; Tsemakhovich VA; Manush EF
    Gematol Transfuziol; 1991 Apr; 36(4):21-3. PubMed ID: 2065962
    [No Abstract]   [Full Text] [Related]  

  • 51. [Self-assembly of soluble X-oligomers].
    Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
    Dokl Akad Nauk; 1999 Apr; 365(4):551-3. PubMed ID: 10368763
    [No Abstract]   [Full Text] [Related]  

  • 52. Cross-linking of fibrinogen by factor XIII zymogen is not apparent in vivo.
    Shainoff JR; DiBello PM
    Thromb Haemost; 2003 May; 89(5):943-4; author reply 944-5. PubMed ID: 12719793
    [No Abstract]   [Full Text] [Related]  

  • 53. Biological properties of fibrinogen derivatives relevant to the function of cardiovascular system and immuno-inflammatory reaction.
    Kopec M
    New Istanbul Contrib Clin Sci; 1977 Sep; 12(1):43-9. PubMed ID: 565049
    [No Abstract]   [Full Text] [Related]  

  • 54. Specificity of thrombin and its action on fibrinogen.
    Blombäck B
    Ann N Y Acad Sci; 1986; 485():120-3. PubMed ID: 3471142
    [No Abstract]   [Full Text] [Related]  

  • 55. The fine structure of fibrin.
    Kay D; Cuddigan BJ
    Br J Haematol; 1967 May; 13(3):341-7. PubMed ID: 4164878
    [No Abstract]   [Full Text] [Related]  

  • 56. Altered immunoelectrophoretic profiles of fibrinogen in full-term newborns.
    Kordich L; Bergonzelli G; Lago O; Sassetti B; Porterie P
    Thromb Res; 1986 Dec; 44(5):695-700. PubMed ID: 3810568
    [No Abstract]   [Full Text] [Related]  

  • 57. A TRANSAMIDASE MECHANISM FOR INSOLUBLE FIBRIN FORMATION.
    Loewy AG; Dahlberg JE; Dorwart WV; Weber MJ; Eisele J
    Biochem Biophys Res Commun; 1964 Mar; 15(2):177-81. PubMed ID: 26410913
    [No Abstract]   [Full Text] [Related]  

  • 58. [Structure, metabolism and pathophysiological importance of fibrinogen].
    Lepsanovic LJ
    Med Pregl; 1976; 29(5-6):287-94. PubMed ID: 940540
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.